Veena
Veena Agarwal, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20140112918 | SYNERGISTIC PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMA OF HEAD AND NECK - The present invention relates to a pharmaceutical combination for use in the treatment of squamous cell carcinoma, comprising a CDK inhibitor selected from the compounds of formula (I); | 04-24-2014 |
Veena Basavaraj, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20140325399 | FRONT-END TOOL FOR DISPLAYING DIAGNOSTIC INFORMATION TO FACILITATE WEB PAGE DEVELOPMENT - The disclosed embodiments relate to a system that displays diagnostic information to facilitate web page development. While a web page is being assembled at a front-end system using data gathered from one or more back-end systems, the system accumulates metadata associated with the assembly process. Next, the system renders the web page using the gathered data. Finally, the system sends the rendered web page along with the metadata to a browser to be displayed to a user, wherein the browser is configured to selectively display the metadata when the web page is displayed. | 10-30-2014 |
Veena Prahlad, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20110123512 | METHOD OF REGULATING THE HEAT SHOCK RESPONSE - The present invention is directed to method of modulating a heat shock response in a first cell of a multicellular organism comprising stimulating or inhibiting an HSR signaling activity of a second cell, wherein the second cell is a neuronal cell that regulates heat shock response activation in the first cell and that does not directly innervate the first cell. | 05-26-2011 |
Veena Rao, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20110027814 | BRCA1 function-based cellular assays - Assays using binding studies involving function of BRCA1a protein have use for diagnosis and for evaluation of possible tumorogenicity of agents, particularly estrogenic agents. The assays do not rely on use of a probe for only specific sequences, but on effects of known and unknown or not previously studied sequences (consequence of genetic changes) or posttranslational modification of BRCA1 proteins (as a consequence of epigenetic changes) as seen in hereditary and sporadic cancers. | 02-03-2011 |
Veena Rathish, Trivandrum IN
Patent application number | Description | Published |
---|---|---|
20160071319 | METHOD TO USE AUGUMENTED REALITY TO FUNCTION AS HMI DISPLAY - A portable computing device includes a camera, a display screen, and a processor. The processor is configured to identify an electronic device from an image of the electronic device captured by the camera, display a virtual human-machine interface (HMI) associated with the electronic device on the display screen, receive user commands through the virtual HMI, and cause the user commands to be communicated to the electronic device. | 03-10-2016 |
Veena Reballi, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20130005709 | SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS - The present invention relates to novel sulfone compounds as 5-HT | 01-03-2013 |
Veena Sahajwalla, New South Wales AU
Patent application number | Description | Published |
---|---|---|
20110197713 | RECARBURISATION METHOD - A method for recarburising a molten ferro-alloy in a ladle or ladle furnace comprises the step of adding a carbon-containing polymer to the ladle or furnace. The polymer is adapted to function as a recarburiser of the ferro-alloy. In this regard, the polymer can have a format which, when it contacts the molten ferro-alloy, promotes dissolution of carbon from the polymer into the molten ferro-alloy. | 08-18-2011 |
Veena Sahajwalla, Sydney AU
Patent application number | Description | Published |
---|---|---|
20100147108 | Production of Ferro-Alloys - A method for producing a Ferro-alloy in an electric arc furnace is disclosed. The method comprises the steps of removing steel from a carbon-containing organic material, and charging the furnace with the carbon-containing organic material product. | 06-17-2010 |
Veena Ts, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20160105313 | CONFIGURATION REPLICATION ACROSS DISTRIBUTED STORAGE SYSTEMS - A method includes receiving a change in a primary configuration of a primary storage node while the primary storage node is operational, wherein primary data stored in the primary storage node is to be backed up as backup data in a backup storage node. The method includes locating at least one identifier in the change that identifies the primary storage node. The method includes replacing the at least one identifier in the change that identifies the primary storage node with an identification of the backup storage node to create an updated configuration change. The method includes updating a backup configuration of the backup storage node based on the updated configuration change. | 04-14-2016 |
Veena Viswanth, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20110038871 | CCR2 INHIBITORS FOR TREATING CONDITIONS OF THE EYE - Disclosed herein are compositions and methods for treating conditions of the eye using CCR2. | 02-17-2011 |
Veena Warikoo, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20150183821 | Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances - Provided herein are integrated continuous biomanufacturing processes for producing a therapeutic protein drug substance. Also provided are systems that are capable of continuously producing a therapeutic protein drug substance. | 07-02-2015 |
20150202595 | Sterile Chromatography Resin and Use Thereof in Manufacturing Processes - Provided herein are methods of reducing bioburden of (e.g., sterilizing) a chromatography resin that include exposing a container including a composition including a chromatography resin and at least one antioxidant agent and/or chelator to a dose of gamma-irradiation sufficient to reduce the bioburden of the container and the chromatography resin, where the at least one antioxidant agent and/or chelator are present in an amount sufficient to ameliorate the loss of binding capacity of the chromatography resin after/upon exposure to the dose of gamma-irradiation. Also provided are reduced bioburden chromatography columns including the reduced bioburden chromatography resin, compositions including a chromatography resin and at least one chelator and/or antioxidant agent, methods of performing reduced bioburden column chromatography using one of these reduced bioburden chromatography columns, and integrated, closed, and continuous processes for reduced bioburden manufacturing of a purified recombinant protein. | 07-23-2015 |
20150203529 | STERILE CHROMATOGRAPHY AND MANUFACTURING PROCESSES - Provided herein are methods of performing chromatography with gamma-irradiated chromatography resin that include providing a chromatography column including a gamma-irradiated chromatography resin; performing a first cycle of chromatography through the column, where the cycle includes exposing the chromatography resin to a denaturing buffer; and performing at least one additional cycle of chromatography through the column. Also provided are integrated, closed or substantially closed, and continuous processes for manufacturing of a recombinant protein that include the use of at least one chromatography column including gamma-irradiated chromatography resin, where the gamma-irradiated chromatography resin is exposed to denaturing buffer during each cycle in the process, and reduced bioburden buffer is used in the process. | 07-23-2015 |
20150203531 | Sterile Chromatography Resin and Use Thereof in Manufacturing Processes - Provided herein are methods of reducing bioburden of (e.g., sterilizing) a chromatography resin that include exposing a container including a composition including a chromatography resin and at least one antioxidant agent and/or chelator to a dose of gamma-irradiation sufficient to reduce the bioburden of the container and the chromatography resin, where the at least one antioxidant agent and/or chelator are present in an amount sufficient to ameliorate the loss of binding capacity of the chromatography resin after/upon exposure to the dose of gamma-irradiation. Also provided are reduced bioburden chromatography columns including the reduced bioburden chromatography resin, compositions including a chromatography resin and at least one chelator and/or antioxidant agent, methods of performing reduced bioburden column chromatography using one of these reduced bioburden chromatography columns, and integrated, closed, and continuous processes for reduced bioburden manufacturing of a purified recombinant protein. | 07-23-2015 |
20150203532 | STERILE CHROMATOGRAPHY AND MANUFACTURING PROCESSES - Provided herein are methods of performing chromatography with gamma-irradiated chromatography resin that include providing a chromatography column including a gamma-irradiated chromatography resin; performing a first cycle of chromatography through the column, where the cycle includes exposing the chromatography resin to a denaturing buffer; and performing at least one additional cycle of chromatography through the column. Also provided are integrated, closed or substantially closed, and continuous processes for manufacturing of a recombinant protein that include the use of at least one chromatography column including gamma-irradiated chromatography resin, where the gamma-irradiated chromatography resin is exposed to denaturing buffer during each cycle in the process, and reduced bioburden buffer is used in the process. | 07-23-2015 |
20150232505 | Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances - Provided herein are integrated continuous biomanufacturing processes for producing a therapeutic protein drug substance. Also provided are systems that are capable of continuously producing a therapeutic protein drug substance. | 08-20-2015 |
Veena Warikoo, Westford, MA US
Patent application number | Description | Published |
---|---|---|
20140255994 | Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances - Provided herein are integrated continuous biomanufacturing processes for producing a therapeutic protein drug substance. Also provided are systems that are capable of continuously producing a therapeutic protein drug substance. | 09-11-2014 |
20140322699 | Affinity-Based Analytical Purification Of Biotherapeutics For Bioprocess Monitoring - The invention as disclosed herein provides a method for purifying a non-antibody protein from solution, comprising a chromatography step wherein the solution is passed over an affinity construct containing an affinity ligand-coupled solid support, wherein the affinity construct is associated with a bioprocess unit operation, and isolating the non-antibody protein from solution. | 10-30-2014 |
20150275195 | ELUTION OF BIOMOLECULES FROM MULTI-MODAL RESINS USING MES AND MOPS AS MOBILE PHASE MODIFIERS - The present invention relates to methods for purifying or enriching a biomolecule using multimodal resins and an elution buffer containing a Good's buffer. | 10-01-2015 |